Silk Road Medical shareholders reject advisory say-on-pay; elect directors, approve officer liability limit

Silk Road Medical Inc

Say-on-pay failed: 13.9M votes for, 20.2M against (57% against).
All five director nominees elected: Anderson, Lasersohn, Rogers, Weatherman, Zurbay.
Charter amendment to limit officer liability approved: 29.7M for, 3.6M against.
Ratification of PwC as auditor approved: 35.2M for, 0.2M against.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Silk Road Medical Inc: Amended certificate of incorporation to eliminate or limit personal liability of certain officers (effective 2023-06-21).

Change: charter amendment
Effective: 2023-06-21

Exact text from the filing

the Company’s stockholders adopted and approved an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, to eliminate or limit the personal liability of certain officers of the Company to the extent permitted by recent amendments to Delaware law (the “Charter Amendment”)

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Silk Road Medical Inc shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-06-21 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-21

Exact text from the filing

Proposal No. 4 - Ratification of Appointment of Independent Registered Public Accounting Firm. The ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023, was approved by the Company’s stockholders by the following final voting results:

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Silk Road Medical Inc shareholders approved Election of Directors at the 2023-06-21 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-21

Exact text from the filing

Proposal No. 1 - Election of Directors . The three Class I and two Class III director nominees proposed by the Board of Directors of the Company were elected to serve as members of the Board of Directors until the 2024 annual meeting of stockholders and until their successors are duly elected and qualified by the following final voting results:

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Silk Road Medical Inc shareholders rejected Advisory Vote to Approve Named Executive Officer Compensation at the 2023-06-21 meeting.

Proposal: say on pay
Outcome: failed
Meeting: 2023-06-21

Exact text from the filing

Proposal No. 2 - Advisory Vote to Approve Named Executive Officer Compensation . The Company’s stockholders did not approve the advisory vote on the compensation of the Company’s executive officers named in the Company’s definitive proxy statement. The following are final voting results:

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Silk Road Medical Inc shareholders approved Approval of an Amendment to Our Certificate of Incorporation to Eliminate or Limit the Personal Liability of Officers at the 2023-06-21 meeting.

Proposal: charter amendment
Outcome: passed
Meeting: 2023-06-21

Exact text from the filing

Proposal No. 3 - Approval of an Amendment to Our Certificate of Incorporation to Eliminate or Limit the Personal Liability of Officers. The Company’s stockholders adopted and approved the Charter Amendment by the following final voting results:

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001397702-23-000046

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.